This article was originally published in SRA
Australian Health and Medical Research receives funding boost
You may also be interested in...
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
Other antibody treatments have shown efficacy in early-stage disease after faltering in hospitalized patients.
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.